SARS-CoV-2 Neutralizing Antibodies in Chile after a Vaccination Campaign with Five Different Schemes

Using levels of neutralizing antibodies (nAbs), we evaluate the successful Chilean SARS-CoV-2 vaccine campaign, which combines different vaccine technologies and heterologous boosters. From a population-based study performed in November 2021, we randomly selected 120 seropositive individuals, organi...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguilera, Ximena, Hormazábal, Juan, Vial, Cecilia, Cortes, Lina Jimena, González, Claudia, Rubilar, Paola, Apablaza, Mauricio, Ramírez-Santana, Muriel, Icaza, Gloria, Nuñez-Franz, Loreto, Castillo-Laborde, Carla, Ramírez-Riffo, Carolina, Pérez, Claudia, Quezada-Gate, Rubén, Said, Macarena, Vial, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321248/
https://www.ncbi.nlm.nih.gov/pubmed/35891215
http://dx.doi.org/10.3390/vaccines10071051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321248/
https://www.ncbi.nlm.nih.gov/pubmed/35891215
http://dx.doi.org/10.3390/vaccines10071051

Ejemplares similares